A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.
Ron Ofri, DVM, PhD, DECVO, provided veterinary professionals at the Veterinary Meeting & Expo conference ways to make ...